High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Selvakumar, N ^a   Kumar, Vanaja ^a   Balaji, S ^a   Prabuseenivasan, S ^a   Radhakrishnan, R ^a   Sekar, Gomathi ^a   Chandrasekaran, V ^a   Kannan, T ^a   Thomas, Aleyamma ^a   Arunagiri, S ^b   Dewan, Puneet ^c,d   Swaminathan, Soumya ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b State TB Cell Government of Tamil Nadu   (India)

^c WHO India ^*  (India)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS; INDIA; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; SPUTUM SMEAR; VIRUS IDENTIFICATION; ADOLESCENT; ADULT; AGED; DRUG EFFECTS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; TUBERCULOSIS, MULTIDRUG-RESISTANT;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84928920401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117421     Document Type: Article

References (32)

1. Raviglione M, Marais B, Floyd K, Lonnroth K, Getahun H, et al. (2012) Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379: 1902-1913. doi: 10.1016/S0140-6736(12)60727-2 PMID: 22608339
2. WHO (2005) Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2005.349. World Health Organization, Geneva.
3. WHO (2009) Global tuberculosis control: epidemiology, strategy, financing. WHO/HTM/TB/2009.411. World Health Organization, Geneva.
4. WHO (2012) Global tuberculosis report. WHO/HTM/TB/2012.6. World Health Organization, Geneva.
5. WHO (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global repoPT on surveillance and response. WHO/HTM/TB/2010.3. World Health Organization, Geneva.
6. Kart L, Altin R, Tor M, Gulmez I, Oymak SF, et al. (2002) Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis. Ann Clin Microbiol Antimicrob 1: 6. PMID: 12537590
7. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, et al. (2009) Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 13: 1154-1160. PMID: 19723407
8. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V, Narayanan PR (2000) Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuber 47: 27-33.
9. WHO (2009b) Guidelines for surveillance of drug resistance in tuberculosis. Fourth Edition. WHO/HTM/TB/2009.422. World Health Organization, Geneva.
10. CTD (2005) Central TB Division: Module for laboratory technician. Second edition, October, 2005. Available: http://www.tbcindia.nic.in/pdfs/Module%20for%20Laboratory%20Technician.pdf. Accessed 2013 Aug 20.
11. Central TB Division (CTD 2009). Revised National TB Control Programme Training Manual for Mycobacterium tuberculosis Culture & Drug susceptibility testing. Available: http://tbcindia.nic.in/pdfs/Training%20manual%20M%20tuberculosis%20C%20DST.pdf. Accessed 2014 Nov 24.
12. WHO (2001) Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dotsplus. WHO/CDS/TB/2001.288. World Health Organization, Geneva.
13. CTD (2011) Central TB Division: National scale-up plan for the programmatic management of drug-resistant tuberculosis (PMDT). March, 2011. Available: http://www.tbcindia.nic.in/pdfs/National%20PMDT%20Scale-up%20Plan%20-%20India%20-%202011-12.pdf. Accessed 2013 Aug 20.
14. WHO (2008) Anti-tuberculosis drug resistance in the world. FouPTh global repoPT. WHO/HTM/TB/2008.394. World Health Organization, Geneva.
15. Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, et al. (2008) Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microb Drug Resist 14: 227-232. doi: 10.1089/mdr.2008.0823 PMID: 18707239
16. Zhao Y, Xu S, Wang L, Chin P, Wang S, et al. (2012). National Survey of Drug-Resistant Tuberculosis in China. N Engl J Med 366: 2161-2170. doi: 10.1056/NEJMoa1108789 PMID: 22670902
17. Assam-Assam JP, Penlap VB, Cho-Ngwa F, Tedom JC, Ane-Anyangwe I, et al. (2011) Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect Dis 11: 94. doi: 10.1186/1471-2334-11-94 PMID: 21496268
18. Klinkenberg E, van den Hof S, Tursynbayeva A, Kipruto H, Wahogo J, et al. (2012) Integration of HIV testing in tuberculosis drug resistance surveillance in Kazakhstan and Kenya. Int J Tuberc Lung Dis 16: 615-617. doi: 10.5588/ijtld.11.0262 PMID: 22409816
19. Chandrasekaran S, Jagota P, Chaudhuri K (1992) Initial drug resistance to anti-tuberculosis drugs in urban and rural district tuberculosis programme. Indian J Tuber 39: 171-175.
20. Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR (2002) Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis 6: 479-484. PMID: 12068979
21. Paramasivan CN, Venkataraman P (2004) Drug resistance in tuberculosis in India. Indian J Med Res 120: 377-386. PMID: 15520487
22. Gupta PR, Singhal B, Sharma TN, Gupta RB (1993) Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Indian J Med Res 97: 102-103. PMID: 8406629
23. Mahadev B, Kumar P, Agarwal SP, Chauhan LS, Srikantaramu N (2005) Surveillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj. Indian J Tuber 52: 5-10.
24. Panayotis I, Dimitrios P, Simona K, Stavroula N, Marina P, et al. (2011) Cepheid Gene Xpert MTB/RIF Assay for Mycobacterium tuberculosis Detection and Rifampin Resistance Identification in Patients with Substantial Clinical Indications of Tuberculosis and Smear-Negative Microscopy Results. J Clin Micro 49: 3068-3070. doi: 10.1128/JCM.00718-11 PMID: 21677069
25. Ginsburg AS,Woolwine SC, Hooper N, BenjaminWH Jr, BishaiWR, et al. (2003) The rapid development of fluoroquinolone resistance inM. tuberculosis. N Engl J Med 349: 1977-1978. PMID: 14614180
26. Umubyeyi AN, Rigouts L, Shamputa IC, Fissette K, Elkrim Y, et al. (2007) Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey. J Antimicrob Chemother 59: 1031-1033. PMID: 17329272
27. Bozeman L, Burman W, Metchock B, Welch L, Weiner M (2005) Flouroquinolones susceptibility among Mycobacterium tuberculosis from the United States and Canada. Clin Infect Dis 40: 386-391. PMID: 15668861
28. Daniel O, Osman E, Bakare R, Adebiyi P, Ige O, et al. (2011) Ofloxacin resistance among Mycobacterium tuberculosisisolates in two states of south-west Nigeria.African J Res Med 2011 March: 18-20.
29. O'Donnell MR, Zelnick J, Werner L, Master I, Loveday M, et al. (2011).Extensively drug-resistant tuberculosis in women, Kwazulu-natal, South Africa. Emer Inf Dis 17: 1942-1945.
30. Blöndal K, Rahu K, Altraja A,Viiklepp P, Rahu M (2013) Overall and cause-specific mortality among patients with tuberculosis and multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 17: 961-968. doi: 10.5588/ijtld.12.0946 PMID: 23743316
31. Swaminathan S, Paramasivan CN, Ponnuraja C, Iliayas S, Rajasekaran S, et al. (2005) Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India. Int J Tuberc Lung Dis 9: 896-900. PMID: 16104637
32. Myneedu VP, Verma AK, Sharma PP, Behera D A (2011) A pilot study of same day sputum smear examination, its feasibility and usefulness in diagnosis of pulmonary TB. Indian J Tuberc 58: 160-167. PMID: 22533165